Epidemiological trends in nosocomial candidemia in intensive care
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitPurpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilmsEpidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in ItalyTemporal Trends in Blood Stream Infection Isolates from Surgical PatientsHospital epidemiology and infection control in acute-care settings.An extracellular matrix-based mechanism of rapid neutrophil extracellular trap formation in response to Candida albicans.Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT studyComparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitalsClinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 yearsPotent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanismAntifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.One year prospective survey of Candida bloodstream infections in Scotland.A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.Candida parapsilosis, an emerging fungal pathogenSurveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.Invasive candidiasis in non-hematological patients.Septic shock due to candidemia: outcomes and predictors of shock development.Uncommon opportunistic yeast bloodstream infections from Qatar.Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol.Clinical and therapeutic aspects of candidemia: a five year single centre study.Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis.Factors related to outcome of bloodstream infections due to Candida parapsilosis complexClinico-microbiological study of candidemia in a tertiary care hospital of southern part of IndiaAccurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay.Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review.An observational study on the epidemiological and mycological profile of Candidemia in ICU patients.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazoleIntensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational studyBench-to-bedside review: Candida infections in the intensive care unit.Candida species adhesion to oral epithelium: factors involved and experimental methodology used.Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial.A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.Invasive fungal infections in patients with cancer in the Intensive Care Unit.Epidemiology and changes in patient-related factors from 1997 to 2009 in clinical yeast isolates related to dermatology, gynaecology, and paediatrics.Synthetic multivalent antifungal peptides effective against fungi.
P2860
Q21194915-087E3A9E-4C8A-4736-869C-B4ADC9FF55DEQ28537918-E5B18123-DEBA-416F-BD4D-DFECC76C838BQ28740362-82C40045-ED22-4170-B221-513C7FDF8B8BQ30279195-3BD3CEB7-C346-4FE4-992B-6306325F583EQ30429049-EE2B6DFF-C130-48D5-945E-BC3A543FA0BAQ30538659-D31FD95E-53D3-4368-BD37-631BBD46CF33Q31054881-F86D2AFF-06FA-4F04-8518-FC5EB05ED0B5Q33296907-F27D6921-875F-4A0F-88CE-961F8AC045A0Q33618418-1FE24E8A-E0D5-4298-B37F-2A2DD94CAAB2Q33807195-F5F5BD5B-B0BF-4395-B0EA-67FDEA5EFA4FQ33849225-F46BA464-1F39-45E8-B9A5-181C83EC7498Q33903375-5C2B3B4C-0E76-4480-B16A-206EFAB67792Q33910250-6990E212-3170-4260-B379-BA44076E05A9Q34539213-493CA7F2-B6F0-4B76-84B3-9E48965D3E94Q34852747-8477AA26-48F4-4CCC-9F23-F4B1759B2C52Q34856747-B4B8526D-9F16-4CAB-A828-C450771DD962Q34916656-58E3D2BE-1BF7-484C-B324-CF7CD1834509Q35010671-D5786274-4781-4AF1-BAB6-734A5F8395D1Q35119972-91C03AB4-7B15-4341-9A96-4BA520B0C444Q35189199-82486EAC-F158-44F6-87FD-C5DB3CD0B414Q35193171-EE2BD534-B4C9-4BE5-8597-1AB6F5D88098Q35641217-EC5451AF-90FA-4289-A8B2-29C8748A5C45Q35822019-6D2B0DB4-A8DF-4355-8E0F-1D684B593741Q36099691-B07A7722-DED3-4D9B-A1BD-16AA56293F68Q36348507-87090B5C-826B-4B02-982B-A42CBC2B587CQ36362975-AD8FEB85-8D82-4724-9F2C-2023E3B05866Q36465424-67AE8692-36A3-4265-AA05-AF85BDA9E40DQ36516322-F8CF645C-8FFE-4463-8A9C-077039AE03C6Q36521993-1722C0EE-58C2-4A8A-BEB3-B1434F0A69D1Q36584767-A8F218BF-DF44-4033-9B4E-59BB2D7CC29BQ36641985-4C7D1ACF-0D87-44C0-A59F-0C2242A2B140Q36661987-670310FC-4C0D-451B-9926-CC136F55CC82Q36670916-DA147BE9-328B-4EC8-AA17-8D6382D894EBQ36825717-93733674-F3E0-4697-8C7E-B17A69FC439AQ36925821-64FF8177-E03A-48E2-99AD-BE21A8C9FE5DQ37115815-61DAC1E1-7D6C-45DE-BC04-867085AF1ABAQ37336194-0B7B7228-67D9-4D19-B698-25885A9BA730Q37373771-CFF460C0-359E-45D3-B3B7-8CD1FF8EE2DFQ37417354-960DFB98-4B7A-4549-832E-9FDDFEC07E7EQ37548771-E0551A69-5522-4855-B5D1-D8094D23A1B4
P2860
Epidemiological trends in nosocomial candidemia in intensive care
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Epidemiological trends in nosocomial candidemia in intensive care
@ast
Epidemiological trends in nosocomial candidemia in intensive care
@en
Epidemiological trends in nosocomial candidemia in intensive care
@nl
type
label
Epidemiological trends in nosocomial candidemia in intensive care
@ast
Epidemiological trends in nosocomial candidemia in intensive care
@en
Epidemiological trends in nosocomial candidemia in intensive care
@nl
prefLabel
Epidemiological trends in nosocomial candidemia in intensive care
@ast
Epidemiological trends in nosocomial candidemia in intensive care
@en
Epidemiological trends in nosocomial candidemia in intensive care
@nl
P2093
P2860
P3181
P356
P1476
Epidemiological trends in nosocomial candidemia in intensive care
@en
P2093
Alessandro Costa
Claudio Viscoli
Franco Bobbio Pallavicini
Maria Pia Molinari
Matteo Bassetti
Raffaella Rosso
Roberta Fasce
P2860
P2888
P3181
P356
10.1186/1471-2334-6-21
P407
P50
P577
2006-02-10T00:00:00Z
P5875
P6179
1030116738